RxDoctor Payments Data

Andrea Eberle, OD

Optometrist · Anchorage, AKNPI 1376742452

Payments from drug & device makers

What this record shows

The money is spread across several categories — other (44.4%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by Carl Zeiss Meditec USA, Inc. at 44.4% of the total. Reporting peaked in 2023 at $5,238 and has fallen 95.1% since, to $258 in 2025. Among optometrist clinicians in AK with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$10,049in general payments, 2019–2025

Across 111 payments — averaging $90.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Carl Zeiss Meditec USA, Inc.$4K
  • Alcon$4K
  • Optos, Inc.$508
  • Bausch & Lomb Americas Inc.$377
  • Coopervision Inc.$158
  • Bausch & Lomb, A Division Of Bausch Health US, LLC$149
  • plus $754 from 10 others

What the payments were for

  • Travel & lodging$1,38414%
  • Food & beverage$3,65836%
  • Gifts$340%
  • Entertainment$5085%
  • Other$4,46444%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,049 in reported general payments places this provider in the 95th percentile of 163 optometrist providers in Alaska.

See all optometrist providers in Alaska

Medicare billing

Part B allowed, 2024
$55,447
Medicare patients
213
Services billed
582

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Prednisolone Acetate36$1,212

Paid to pharmacies, not to this prescriber.

Other optometrist in Anchorage

See the full list for Alaska

Where these figures come from

Is this you, or does something look wrong? →